Abstract:Finding new therapeutic approaches towards colorectal cancer (CRC) is of increased relevance, as CRC is one of the most common cancers worldwide. CRC standard therapy includes surgery, chemotherapy, and radiotherapy, which may be used alone or in combination. The reported side effects and acquired resistance associated with these strategies lead to an increasing need to search for new therapies with better efficacy and less toxicity. Several studies have demonstrated the antitumorigenic properties of microbiota-derived short-chain fatty acids (SCFAs). The tumor microenvironment is composed by non-cellular components, microbiota, and a great diversity of cells, such as immune cells. The influence of SCFAs on the different constituents of the tumor microenvironment is an important issue that should be taken into consideration, and to the best of our knowledge there is a lack of reviews on this subject. The tumor microenvironment is not only closely related to the growth and development of CRC but also affects the treatment and prognosis of the patients. Immunotherapy has emerged as a new hope, but, in CRC, it was found that only a small percentage of patients benefit from this treatment being closely dependent on the genetic background of the tumors. The aim of this review was to perform an up-to-date critical literature review on current knowledge regarding the effects of microbiota-derived SCFAs in the tumor microenvironment, particularly in the context of CRC and its impact in CRC therapeutic strategies. SCFAs, namely acetate, butyrate, and propionate, have the ability to modulate the tumor microenvironment in distinct ways. SCFAs promote immune cell differentiation, downregulate the expression of pro-inflammatory mediators, and restrict the tumor-induced angiogenesis. SCFAs also sustain the integrity of basement membranes and modulate the intestinal pH. CRC patients have lower concentrations of SCFAs than healthy individuals. Increasing the production of SCFAs through the manipulation of the gut microbiota could constitute an important therapeutic strategy towards CRC due to their antitumorigenic effect and ability of modulating tumor microenvironment.

Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics

Gut microbiota modulation: a tool for the management of colorectal cancer

Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer

Gut Microbiota Impacts on the Efficacy of Anticancer Treatment of Colorectal Cancer

Gastrointestinal cancers: the role of microbiota in carcinogenesis and the role of probiotics and microbiota in anti-cancer therapy efficacy

Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers

Gut Microbiota—Adversary or Ally? Its Role and Significance in Colorectal Cancer Pathogenesis, Progression, and Treatment

Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies

Microbiome modulation in the prevention and management of colorectal cancer: a systematic review of clinical interventions

Strategies for the treatment of colorectal cancer caused by gut microbiota

Gut microbiome in tumorigenesis and therapy of colorectal cancer

Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy

Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?

Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota

Gut Microbiome–Colorectal Cancer Relationship

Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy

Targeting the gut microbiota for cancer therapy

Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer

Gut microbiota: impacts on gastrointestinal cancer immunotherapy

Gut microbiota in colorectal cancer development and therapy

Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies